GHRP-2-Gly
Two analytical papers found that Gly-GHRP-2 is GHRP-2 with one more glycine at its start (PMID 29864719; PMID 30051972; checked 24 Aug 2026). One used custom synthesis to confirm the identity. The other tested a seized injection vial. Neither gave it to people. PubMed lists no grant for either paper.
What is GHRP-2-Gly?
GHRP-2-Gly and Gly-GHRP-2 name the same seven-part analogue. It is GHRP-2 with one glycine at the start (PMID 29864719; checked 24 Aug 2026).
That extra residue makes it a different compound from GHRP-2. Human GHRP-2 results do not move to this record.
What did the analytical papers find?
| Source | Material | Finding | Checked |
|---|---|---|---|
| PMID 29864719 | Black-market growth products | Gly-GHRP-2 structure found by high-resolution tandem mass spectrometry and confirmed by custom synthesis | 24 Aug 2026 |
| PMID 30051972 | Seized injection vial | A new 874.02 Da heptapeptide identified as the glycine analogue of GHRP-2 | 24 Aug 2026 |
PMID 29864719 also tested in vitro metabolism. It did not report an effect in an animal or person.
What human evidence is available for this exact analogue?
Exact PubMed and ClinicalTrials.gov searches found no test that gave GHRP-2-Gly or Gly-GHRP-2 to a person (checked 24 Aug 2026). No table of bad events for this drug was found.
Are identifiers available for GHRP-2-Gly?
Exact US FDA/NCATS GSRS searches found no record for GHRP-2-Gly or Gly-GHRP-2 (checked 24 Aug 2026). The missing identifier block is an explicit registry absence. A GHRP-2 code must not be copied here.
What does evidence tier D mean here?
The exact drug has analytical identification and in vitro metabolism work. It has no human result. Tier D stays right (checked 24 Aug 2026). The tier does not set public status.
What is the recorded EU status?
The EU Commission index has no exact entry for GHRP-2-Gly or Gly-GHRP-2 (Union Register index; checked 24 Aug 2026). The EU field stays unclear.
When was GHRP-2-Gly first observed in a product?
PMID 29864719 first came out in May 2018 and reports the tested black-market product. It supports 2018-05 as a paper by-date, not the month the product was found (checked 24 Aug 2026).
What does this register entry cover?
This entry covers only the form with one more glycine. It does not move findings from GHRP-2.
→ GHRP-2 register entry → What can be in a vial → All register entries